PNPLA7 and hepatocellular carcinoma: The promoter region of the PNPLA7 gene is hypermethylated in several human hepatocellular carcinoma cell lines, including HepG2 and Huh7, and treatment of the cells with a DNMT inhibitor increases PNPLA7 expression [51].